04UD4JZ
Supplement Common Iliac Artery, Left to No Qualifier with Synthetic Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 4 Lower Arteries |
| Operation | U Supplement |
| Body Part | D Common Iliac Artery, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures reinforce or augment an artery using additional biological or synthetic material without removing the native vessel segment, distinguishing them from Replacement, where the diseased tissue is excised. In the lower arteries this typically takes the form of patch angioplasty at an endarterectomy site, or endovascular placement of a covered stent graft that lines and reinforces a weakened or aneurysmal segment while the native artery remains in place.
Patients undergo this type of procedure when an artery has been narrowed by plaque removal and needs a widening patch to prevent restenosis, or when an aneurysm needs endoluminal reinforcement rather than open resection. It is common in both open vascular surgery and increasingly in endovascular aneurysm repair, where covered stent grafts are deployed to reinforce the arterial wall from within.
Anatomy & Axis Detail
Common Iliac Artery, Left
The left common iliac artery mirrors its right-sided counterpart, running from the aortic bifurcation to its own division into internal and external iliac branches, and is anatomically situated near the sigmoid colon and left ureter. Supplement procedures on this vessel reinforce a weakened or aneurysmal wall segment, commonly as an extension of aortic aneurysm repair or to correct a residual defect at an endograft's distal landing zone, using synthetic or biologic material applied along the existing arterial wall. Because the left common iliac vein crosses beneath this artery, operative approach and repair technique must account for that adjacent venous structure, and documentation should specify laterality clearly since bilateral common iliac disease is common in diffuse aortoiliac atherosclerosis.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
Coders should confirm from the operative note that the native artery segment was left in place and that material, whether a bovine pericardial patch, synthetic patch, or covered endograft, was added to reinforce or widen it. The device value must reflect the specific material used, and the body part value should reflect the arterial segment being reinforced, which for endovascular aneurysm repair can span multiple named segments requiring multiple codes.
A frequent error is coding patch angioplasty performed after an endarterectomy as part of the Extirpation code for the plaque removal rather than as a separate Supplement code, when current guidance requires both steps to be captured. Another common mistake is applying Replacement device values to what is actually a reinforcing supplement.